Product/Composition:- | Lisinopril Tablets |
---|---|
Strength:- | 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg |
Form:- | Tablet |
Reference Brands:- | Prinivil, Zestril(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Lisinopril tablets are ACE inhibitors that block the conversion of angiotensin I to angiotensin II, a vasoconstrictor. Benefits include lowering blood pressure, reducing the risk of strokes and heart attacks, and treating heart failure. They improve cardiovascular health, ease workload on the heart, and protect kidney function.
Lisinopril tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and quality compliance with GMP standards. In the US, regulations are overseen by the FDA, while in the EU, EMA manages approval processes. These dossiers include clinical trial data, stability, manufacturing practices, and safety profiles. Lisinopril is widely prescribed for hypertension, heart failure, and kidney protection, with market authorization granted after rigorous evaluation. For detailed licensing, approved dossiers, and regulatory updates in global markets, visit Pharmatradz. Stay informed on the latest regulatory requirements for lisinopril and ensure compliance for market success.